Myotonic Dystrophy Type 1

CRISPR CAS9 gene editing background

UT Southwestern-Linked Startup Exonics Therapeutics Exits in Deal Valued at $1B

by | Jun 17, 2019
The biotech company uses CRISPR technology licensed from UT Southwestern Medical Center in Dallas, and was co-founded by UTSW researcher and faculty member Eric Olson.
MORE